Verastem | VSTM - Spese Di Vendita E Di Amministrazione





Spese Di Vendita E Di Amministrazione Cambiamento Data
AbbVie USD 3.58B 316M 2026-03
Alaunos Therapeutics USD 447K 138K 2026-03
AstraZeneca USD 5.06B 455M 2026-03
Curis USD 1.34M 3.45M 2025-12
Cytokinetics USD 104.9M 13.17M 2026-03
Gilead Sciences USD 1.45B 326M 2026-03
Incyte USD 328.1M 62.31M 2026-03
Laboratory Of America USD 551M 12.4M 2026-03
Novartis USD 3.14B 296M 2026-03
Pfizer USD 2.92B 1.16B 2026-03
Roche Holding CHF 7.28B 3.99B 2025-12
TG Therapeutics USD 73.14M 22.42M 2026-03
Verastem USD 24.44M 12.17M 2025-12